International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinomaAnne W.M. Lee, Joseph Wee, Wai Tong Ng et al.|Radiotherapy and Oncology|2017Cited by 374
Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell CarcinomaAaron J. Grossberg, David I. Rosenthal, Sasikarn Chamchod et al.|JAMA Oncology|2016Cited by 241
Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer – A case matched analysisPierre Blanchard, Steven J. Frank, Joseph Crutison et al.|Radiotherapy and Oncology|2016Cited by 231
Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i> BRAF <sup>V600E</sup> </i> -Mutated Anaplastic Thyroid CarcinomaJennifer Wang, Maria E. Cabanillas, Mark Zafereo et al.|Thyroid|2019Cited by 229
Beam Path Toxicities to Non-Target Structures During Intensity-Modulated Radiation Therapy for Head and Neck CancerDavid I. Rosenthal, Adam S. Garden, Mark S. Chambers et al.|International Journal of Radiation Oncology*Biology*Physics|2008Cited by 199